Endo Int\'l (ENDP) Acquires Natesto Gel Rights from Trimel BioPharma
Tweet Send to a Friend
Endo Int\'l (NASDAQ: ENDP) the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
